Urokinase
生产企业：Microbix biosystems inc
Urokinase is a low molecular weight form of human urokinase used to treat pulmonary embolism and myocardial infarction as well as to clear IV lines.
Urokinase is a low molecular weight form of human urokinase used to treat pulmonary embolism and myocardial infarction as well as to clear IV lines.
Urokinase is a serine protease. It cleaves plasminogen to form the active fibrinolytic protease, plasmin.
In Canada, urokinase is indicated for lysis of acute massive pulmonary emboli, acute thrombi obstructing coronary arteries, occlusive thromboemboli in peripheral arteries and grafts, and restoration of patency to intravenous catheters.
共 6 项相关疾病
每项发明一条，涵盖美国、欧洲、PCT 与中国的同族专利。
